Table 2 Prevalence of first psychotropic medication purchases (%) during the follow-up
| Â | n | Any (%) | Antidepressants (%) | Sedatives (%) |
|---|---|---|---|---|
All | 6169 | 29.7 (28.6–30.9) | 20.1 (19.1–21.1) | 18.3 (17.3–19.3) |
Highly active normal-weight | 1397 | 27.0 (24.7–29.3) | 17.3 (15.3–19.2) | 16.3 (14.4–18.3) |
Moderately active normal-weight | 1198 | 30.4 (27.8–33.0) | 20.2 (17.9–22.5) | 19.5 (17.3–21.8) |
Inactive normal-weight | 561 | 33.2 (29.3–37.1) | 23.5 (20.0–27.0) | 19.8 (16.5–23.1) |
Highly active overweight | 947 | 25.3 (22.6–28.1) | 16.8 (14.4–19.2) | 15.5 (13.2–17.8) |
Moderately active overweight | 1185 | 31.3 (28.7–34.0) | 21.4 (19.1–23.8) | 19.4 (17.2–21.7) |
Inactive overweight | 881 | 33.5 (30.4–36.6) | 23.7 (20.9–26.5) | 20.3 (17.7–23.0) |